Dopamin i njegovi metaboliti u likvoru alkoholičara sa infarktom mozga

M. Radomirović ,
M. Radomirović
Slavica Đukić Dejanović ,
Slavica Đukić Dejanović
M. Nenadović
M. Nenadović

Published: 15.01.2014.

Volume 42, Issue 2 (2013)

pp. 7-11;

Abstract

Alkoholizam je jedan od 300 do danas istraženih i utvrđenih faktora rizika za nastanak infarkta mozga. Redukovan broj neurona zbog moždanog infarkta i premorbidnog alkoholizma, uz brojne poremećaje funkcije mozga, za posledicu mora imati i oštećen metabolizam dopamina (DA), tj. metaboličkog obrta DA (3, 4 dihydroxyphenylacetic acid + homovanilic acid, DOPAC + HVA). Osnovni cilj istraživanja je dokazivanje poremećaja koncentracijskog sadržaja DA i metaboličkog obrta DA kod bolesnika sa moždanim infarktom, a premorbidnih alkoholičara, biohemijskim pregledom likvora, i to u poređenju sa nalazom u likvoru bolesnika bez akutne moždane lezije. Formirane su dve grupe hospitalno lečenih bolesnika za svrhe ovog istraživanja. Ispitivanu grupu A čini 50 bolesnika sa akutno nastalim moždanim infarktom a premorbidnih alkoholičara. Svi su mlađi od 65 godina. Kontrolnu grupu (grupa B) čini 30 bolesnika hospitalno lečenih zbog vertiginoznih smetnji, a mlađih od 65 godina. Likvor (CSF) uzet je neposredno pri prijemu na bolničko lečenje bolesnicima grupe A, a bolesnicima kontrolne grupe B u prvoj sedmici hospitalizacije i čuvan na -70°C do pregleda. Laboratorijski je utvrđen povišen sadržaj DA, kao i njegovih metabolita (DOPAC + HVA) u likvoru bolesnika sa moždanim infarktom a ranijih alkoholičara za p<0,05. Rezultati sugerišu da DA ima značajnu ulogu u nastanku ishemijskog oštećenja. Nalaz ukazuje na značajno ubrzanje metabolizma DA kod bolesnika sa moždanim infarktom a ranijih alkoholičara. Pored toga potvrđuje i značaj DA u patogenezi ishemijske smrti neurona.

Keywords

References

1.
Chatterjee D, Gerlai R. High precision liquid chromatography analysis of dopaminergic and serotoninergic responses to acute alcohol exposure in zebrafish. *Behavioural Brain Research*. 2009;200(1):208–13.
2.
Čolić S, Nenadović M, Smilić L, Marjanović J. Faktori rizika za nastanak akutnog moždanog udara, praćenje indeksa ateroskleroze i IIGM. *Praxis Medica*. 2008;36(3–4):33–6.
3.
Čolić S, Smilić L, Nenadović M, Trajković G, Marjanović J. Migrena udružena sa aneurizmom ACM kod 15-togodišnje pacijentkinje - prikaz slučaja. *Praxis Medica*. 2008;36(1–2):123–6.
4.
Gorgoraptis N, Mah Y, Machner B, Singh-Curry V, Malhotra P, Hadji-Michael M, et al. The effects of the dopamine agonist rotigotine on hemispatial neglect following stroke. *Brain*. 2012;135(Pt 8):2478–91.
5.
Iastrebtseva IP, Novikov AE. Post-stroke somatic pathology in patients with a history of alcohol abuse. *Terapevticheskiĭ Arkhiv*. 2010;82(10):24–8.
6.
Melis M, Diana M, Enrico P, Marinelli M, Brodie MS. Ethanol and acetaldehyde action on central dopamine systems: mechanisms, modulation, and relationship to stress. *Alcohol. 2009;43(7):531–9.
7.
Nakayama K, Oshima Y, Tachibana T, Furuse M, Honjo T. Alteration of monoamine concentrations in the brain of medaka, *Oryzias latipes*, exposed to tributyltin. *Environmental Toxicology*. 2007;22(1):53–7.
8.
Nenadovic M, Vicentic S, Nenadovic NM, Jasovic-Gasic MM. Correlation of pre-morbid alcoholism and changes in the level of biogenic amine metabolites in cerebrospinal fluid of acute brain infarction patients. *Psychiatria Danubina*. 2011;23(2):165–70.
9.
Nenadović M. *Disorders of cognitive functions in alcoholics and non-alcoholics with brain infarction.*. 1993.
10.
Prugger C, Luc G, Haas B, Morange PE, Ferrieres J, Amouyel P, et al. Group on behalf of the P.S.**. The PRIME Study *Arteriosclerosis, Thrombosis, and Vascular Biology*. 2013;33(3):659–66.
11.
Quintanilla ME, Bustamante D, Tampier L, Israel Y, Herrera-Marschitz M. Dopamine release in the nucleus accumbens (shell) of two lines of rats selectively bred to prefer or avoid ethanol. *European Journal of Pharmacology*. 2007;573(1–3):84–92.
12.
Shukir MAO, Aziz AA, Xaznadar A, Shaikhani M. Striatocapsular infarction; a single institutional experience. *Acta Informatica Medica*. 2012;20(2):106–12.
13.
Strawn JR, Ekhator NN, Geracioti TD. In-use stability of monoamine metabolites in human cerebrospinal fluid. *Journal of Chromatography B, Biomedical Sciences and Applications*. 2001;760(2):301–6.
14.
Wagner AK, Ren D, Conley YP, Ma X, Kerr ME, Zafonte RD, et al. Sex and genetic associations with cerebrospinal fluid dopamine and metabolite production after severe traumatic brain injury. *Journal of Neurosurgery*. 2007;106(4):538–47.
15.
Wąsik A, Romańska I, Antkiewicz-Michaluk L. 1-Benzyl-1,2,3,4-Tetrahydroisoquinoline, an endogenous Parkinsonism-inducing toxin, strongly potentiates MAO-dependent dopamine oxidation and impairs dopamine release: ex vivo and in vivo neurochemical studies. *Neurotoxicity Research*. 2009;15(1):15–23.

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by